Generics on the way? Top drugs in danger of losing patent protection
Generic drug entry tends to signal the end of an era — patents expire, competitors reach settlements and prices are cut.
The storyline tends to play out in mostly the same way: patents and exclusivity protections eventually expire, competition swoops in, and within a few months, they’ve transformed the market into a new, less expensive and less marketed landscape.
At least that’s the theory. The reality isn’t always that simple.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
